Forging a position as an innovative player in
infectious disease vaccines and therapies
Home
About
Company Overview
Board and management
News
Our Technology
Technology and Products
LAIV
BDM-I
About Our Disease Targets
Business Development
Partner Network
Licensing Strategy and Available Licenses
Investor Relations
Announcements
Financial Reports
Share trading
Videos
Corporate governance
Newsletters
Media
Contact Us
Corporate directory
BioDiem
» » BioDiem Board Changes
BioDiem Board Changes
March 29, 2022 •
Category
•
Author Name
Read the
full announcement
Latest News
Half Year Financial Report
May 23, 2025
Half Year Financial Report
Read More
2024 AGM CEO Presentation
December 3, 2024
2024 AGM CEO Presentation
Read More
